CURRENT CLINICAL INTERESTS
Thrombotic disorders, including antiphospholipid syndrome and cancer-associated venous thromboembolism.
CURRENT RESEARCH INTERESTS
Clinical investigation, including outcomes-based and comparative effectiveness research. Main focus: novel oral anticoagulants, warfarin reversal, VTE risk prediction, and perioperative anticoagulation.
Garcia D, Akl EA, Carr R, Kearon C. Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review. Blood. 122(5):817-24, 2013.
Garcia D, Barrett YC, Ramacciotti E, Weitz JI. Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants. J Thromb Haemost. 11: 245–52, 2013.
Siegal DM, Garcia D. Anticoagulants in cancer. J Thromb Haemost. 10: 2230–41, 2012.
Garcia DA, Crowther MA. Reversal of warfarin: case-based practice recommendations. Circulation. 125(23):2944-7, 2012.
Garcia D, Crowther MA, Ageno W. Practical management of coagulopathy associated with warfarin. BMJ. 19;340:c1813, 2010.
Crowther M, Ageno W, Garcia D, Wang L, Witt D, and others. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med. 150:293-300, 2009.
Garcia D, Regan S, Henault LE, Upadhyay A, Baker J, Othman M, Hylek EM. Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med. 168(1):63-9; 2008.